Literature DB >> 32035804

Interrater reliability in pupillary assessment among intensive care nurses.

Ayda Kebapcı1, Serpil Topçu2.   

Abstract

BACKGROUND: Pupillary abnormalities are a common and reliable finding of brain herniation, ischaemia, and acute brain injury in critically ill patients. Reliable pupil assessment is a vital evaluation in diagnostic and therapeutic procedures for neurocritical patients. AIM: To evaluate inter-rater reliability of pupillary assessment among intensive care.
METHODS: In this prospective, blind observational study, intensive care nurses and two researchers evaluated the pupil size, reactivity and symmetry of 200 patients with neurosurgery or neurological diseases. A total of 200 pupillary measurement sets were completed independently and blindly.
RESULTS: Three observers -two researchers and the nurse- found fair-to-good and excellent agreements in initial pupil size evaluations of right and left pupils, respectively (ICC = 0.70, 95%; ICC = 0.75, 95%). In patients with pupil size ≥4 mm, the observers found fair-to-good agreements in both right and left pupil initial size measurements (ICC = 0.52; ICC = 0.65). Agreement in pupil symmetry was moderated (K = 0.58), and reactivity was near perfect (K = 0.89) between the three observers.
CONCLUSION: Although the two researchers found near perfect agreement in pupil size, symmetry and reactivity assessment, two researchers and the nurse found moderate agreement in pupil symmetry and fair-to-good agreement in pre- and post-light stimulation pupil size.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Critical care; Neurology; Neurosurgery; Nurses; Pupil

Year:  2020        PMID: 32035804     DOI: 10.1016/j.iccn.2020.102801

Source DB:  PubMed          Journal:  Intensive Crit Care Nurs        ISSN: 0964-3397            Impact factor:   3.072


  1 in total

1.  Prehospital clinical signs are a poor predictor of raised intracranial pressure following traumatic brain injury.

Authors:  Ewoud Ter Avest; Sam Taylor; Mark Wilson; Richard L Lyon
Journal:  Emerg Med J       Date:  2020-09-18       Impact factor: 2.740

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.